Hirschsprung Disease

Overview
Pathophysiology — Neural Crest Migration Failure
Genetics — RET Proto-Oncogene and Associated Syndromes
Anatomy of Aganglionosis — Extent Determines Severity
Clinical Presentation — Neonates and Older Children
Hirschsprung-Associated Enterocolitis (HAEC)
Diagnosis — Suction Rectal Biopsy and Barium Enema
Differential Diagnosis
Treatment — Pull-Through Surgery
Long-Term Outcomes and Complications
Research Papers
Connections
Featured Videos

Overview

Hirschsprung disease (HSCR), also called congenital megacolon or aganglionic megacolon, is a congenital disorder in which the distal bowel lacks ganglion cells in both the myenteric (Auerbach's) plexus and the submucosal (Meissner's) plexus — the two nerve networks that coordinate peristaltic contractions throughout the gut wall. Without these ganglion cells, the affected segment has no coordinated peristalsis, remains in a state of tonic contraction, and creates a functional obstruction. Stool cannot pass through the aganglionic zone. The bowel proximal to the obstruction — where ganglion cells are present — dilates progressively under the pressure of backed-up intestinal contents, producing the characteristic megacolon: a massively dilated proximal bowel ballooning above a tight, narrow aganglionic segment below.

Hirschsprung disease was first described by the Danish pediatrician Harald Hirschsprung in 1888, who reported two infants with massive colonic dilatation at autopsy. For decades the dilated segment was mistakenly thought to be the diseased portion. The critical insight — that the narrow distal segment is the true pathological zone because it lacks ganglion cells — was not established until the 1940s by Robertson and Kernohan, and was confirmed by Swenson and Bill in 1948, who also developed the first curative surgical procedure. The disease is named for Hirschsprung, though he never identified the underlying pathology.

HSCR occurs in approximately 1 in 5,000 live births and is the most common cause of congenital intestinal obstruction in newborns after intestinal atresia. It is four times more common in males than females for short-segment disease (the most common form), though the sex ratio narrows to approximately equal for long-segment disease. HSCR spans a wide clinical spectrum — from neonates who present in the first days of life with failure to pass meconium and abdominal distension, to children and rare adults with lifelong severe constipation whose disease was never recognized.

Back to Table of Contents

Pathophysiology — Neural Crest Migration Failure

The enteric nervous system — the intrinsic nervous system of the gut, sometimes called the "second brain" — develops entirely from neural crest cells, a transient population of embryonic cells that migrate from the dorsal neural tube throughout the body to form diverse tissues including peripheral neurons, melanocytes, and craniofacial structures. The enteric nervous system is unique in that its neural crest cell precursors must execute one of the longest and most complex migration journeys in embryology: they enter the foregut at the level of the esophagus around gestational week 5 and then migrate progressively in a craniocaudal direction — headward to tailward — colonizing the entire length of the gut as they travel down. They reach the proximal colon by week 7, the splenic flexure by week 9, and the rectum by week 12.

In Hirschsprung disease, this migration arrests prematurely. Neural crest cell precursors fail to reach the distal bowel, leaving the rectum and a variable length of colon above it completely devoid of ganglion cells — a state called aganglionosis. The precise level where migration stopped determines the extent of the disease. The distal rectum, which is always involved, is the last territory the migrating cells must reach; this is why the aganglionic segment invariably includes the rectum and extends to variable lengths proximally, but never spares the rectum while involving more proximal bowel.

The aganglionic segment is characterized by three pathological features that together produce the obstruction:

Absence of ganglion cells in both the myenteric and submucosal plexuses. Ganglion cells are the final-order neurons that coordinate smooth muscle contraction and relaxation. Without them, there is no inhibitory neural input to the smooth muscle, which therefore remains in tonic contraction.
Hypertrophy and hyperplasia of extrinsic nerve fibers — large, thickened nerve trunks (extrinsic sympathetic and parasympathetic fibers) proliferate into the aganglionic segment in the absence of ganglion cells. These large nerve trunks stain intensely for acetylcholinesterase (AChE) — the enzyme that breaks down acetylcholine — and this increased AChE staining is a key histochemical marker used in diagnosis.
Failure of internal anal sphincter relaxation — normally, rectal distension triggers reflex relaxation of the internal anal sphincter (the rectoanal inhibitory reflex, RAIR) to allow defecation. This reflex is mediated by ganglion cells in the submucosal plexus. In HSCR, these cells are absent, the RAIR is absent, and the sphincter fails to relax — a physiological finding that can be detected by anorectal manometry and that provides another diagnostic tool.

The result of these abnormalities is a functionally obstructed, tonically contracted distal segment through which stool cannot pass. The normal, ganglionated bowel above dilates under the pressure of accumulated fecal matter, producing the megacolon that is visible on imaging and at surgery — massive dilation of the normal bowel proximal to a narrow, pathological aganglionic segment below.

Back to Table of Contents

Genetics — RET Proto-Oncogene and Associated Syndromes

Hirschsprung disease has a complex genetic architecture. The most important identified genetic factor is the RET proto-oncogene on chromosome 10q11.2. RET encodes a receptor tyrosine kinase that is expressed on neural crest cells and is essential for their survival, proliferation, and migration during gut colonization. RET is activated by its ligand, glial cell line-derived neurotrophic factor (GDNF), which binds to RET through a co-receptor called GFR-α1. The GDNF-GFR-α1-RET signaling axis is the master switch for enteric nervous system development; loss-of-function mutations in RET disable this axis and arrest neural crest migration.

Loss-of-function RET mutations are found in ~50% of familial HSCR cases and 15–20% of sporadic cases.
RET mutations are more common in long-segment HSCR than short-segment.
Beyond RET, mutations in EDNRB (endothelin receptor type B), EDN3 (endothelin-3), GDNF, NRTN (neurturin), SOX10, and several other genes have been identified, each accounting for a smaller fraction of cases.
Most HSCR is autosomal dominant with incomplete penetrance and variable expressivity — meaning that a single mutant allele can cause disease, but not every carrier develops HSCR, and when they do, the segment length varies. This explains why families may have members with differing severity or no disease despite carrying the same mutation.
A common variant in the RET enhancer element in intron 1 — not a coding mutation but a regulatory change — is associated with increased HSCR susceptibility in otherwise sporadic cases, and has been identified by genome-wide association studies.

HSCR can occur in isolation or as part of defined syndromes with other congenital anomalies:

Down syndrome (Trisomy 21) — the most important association; approximately 10% of Hirschsprung disease patients have Down syndrome, and the risk of HSCR in a child with Down syndrome is approximately 1 in 100 (vs 1 in 5,000 in the general population). The mechanism likely involves haploinsufficiency of genes on chromosome 21 that modify RET signaling. Children with Down syndrome and HSCR have higher rates of HAEC and more complex post-surgical outcomes.
Waardenburg syndrome (WS4) — association of HSCR with the triad of sensorineural hearing loss + depigmentation (white forelock, heterochromic irides) + aganglionic megacolon; caused by mutations in SOX10, EDNRB, or EDN3; also called Waardenburg-Shah syndrome or Waardenburg type 4.
Multiple Endocrine Neoplasia type 2A (MEN2A) — caused by gain-of-function RET mutations (paradoxically, the same gene that causes loss-of-function HSCR); syndrome of medullary thyroid carcinoma + pheochromocytoma + parathyroid hyperplasia; HSCR can co-occur in MEN2A families with specific RET codon 620 mutations; requires genetic counseling for both malignancy surveillance and bowel disease.
Bardet-Biedl syndrome, Goldberg-Shprintzen syndrome, Mowat-Wilson syndrome — each has HSCR as a recognized but less common feature.
Children diagnosed with HSCR should be evaluated for associated anomalies; chromosomal microarray and multigene panel testing is increasingly recommended for syndromic or familial cases.

Back to Table of Contents

Anatomy of Aganglionosis — Extent Determines Severity

The extent of the aganglionic segment is the single most important determinant of clinical severity, surgical complexity, and long-term outcomes in Hirschsprung disease. The segment always begins at the internal anal sphincter — the rectum is invariably involved — and extends upward for a variable distance:

Short-segment HSCR (75–80% of cases): Aganglionosis is limited to the rectosigmoid junction and below. This is by far the most common form. It shows a strong male predominance (4:1 to 5:1). It is typically diagnosed in the neonatal period with classic signs (failure to pass meconium, abdominal distension), though some cases with milder presentations are diagnosed later in infancy or childhood. Short-segment disease is generally amenable to a primary single-stage pull-through surgery with excellent outcomes.

Long-segment HSCR (approximately 15% of cases): Aganglionosis extends proximal to the sigmoid colon, into the descending colon or beyond. Clinical presentation is typically more severe, surgical resection requires removing more bowel, and the risk of post-operative constipation and enterocolitis is higher. The sex ratio is more equal in long-segment disease (~2:1 male:female) than in short-segment disease, suggesting differing genetic mechanisms.

Total colonic aganglionosis (TCA, fewer than 5% of cases): The entire colon is aganglionic, and the aganglionic segment may extend variable distances into the terminal ileum or even more proximal small bowel. TCA is the most severe and surgically challenging form. The barium enema appearance is different from typical HSCR: instead of a classic transition zone with a dilated proximal colon, the entire colon is small-caliber and shortened (a "microcolon" or "question-mark" appearance), because without ganglion cells the entire colon has never functioned normally and never dilated. The diagnosis of TCA is often delayed because the expected barium enema transition zone is absent. Management requires resection of the entire aganglionic colon with ileoanal or ileorectal pull-through, and outcomes — while improved — remain more complex than short-segment disease.

Total intestinal aganglionosis: Aganglionosis of the entire intestine from small bowel to rectum — exceedingly rare, almost always fatal without intestinal transplantation, and incompatible with life if untreated.

The key principle is that the transition zone — the region between ganglionated and aganglionic bowel, which on barium enema appears as a cone-shaped narrowing where the normal dilated bowel tapers to the narrower aganglionic segment — is the landmark that guides both diagnosis and surgical planning. Identifying the transition zone, and performing rectal biopsies to confirm the proximal extent of ganglionated bowel, are fundamental to curative surgery.

Back to Table of Contents

Clinical Presentation — Neonates and Older Children

The clinical presentation of Hirschsprung disease varies substantially depending on the age at diagnosis and the extent of aganglionosis. The most important and characteristic neonatal sign is failure to pass meconium within 48 hours of birth.

Neonatal presentation (most common):

Failure to pass meconium within 48 hours of birth — the single most important diagnostic clue. Normal term infants pass their first meconium stool within 24–48 hours of birth; approximately 90% of term neonates with HSCR fail to do so. Any term newborn who has not passed meconium by 48 hours requires evaluation for HSCR (other causes: intestinal atresia, meconium plug syndrome, cystic fibrosis, hypothyroidism, anorectal malformations).
Abdominal distension — progressive, often visible within hours to days; the distended loops of dilated bowel may produce a tense, tympanic abdomen.
Bilious vomiting — from functional obstruction and backup of intestinal contents.
Feeding difficulties — poor feeding, failure to establish normal feeding routine.
Digital rectal examination finding — insertion of a finger or rectal tube past the tight aganglionic segment into the dilated proximal bowel is immediately followed by a "squirt" or explosive gush of meconium and gas as backed-up contents rush out through the artificially opened obstruction. This explosive stool release after rectal examination is a classic clinical sign.

Older children and adults (delayed or missed diagnosis):

Chronic severe constipation dating from birth — the defining feature; constipation that has existed since the newborn period and has never responded normally to dietary changes or laxatives.
Abdominal distension — often chronic; the abdomen may appear chronically distended and tympanic.
Failure to thrive — in infants and young children; chronic malnutrition from impaired gut function and reduced oral intake.
Absence of encopresis — this is a critical distinguishing feature from functional constipation. Children with functional constipation commonly develop fecal impaction with overflow incontinence (encopresis) — soft stool seeps around the hard impaction and leaks through the sphincter. Children with Hirschsprung disease generally do not develop encopresis because the tight aganglionic segment prevents any passage of stool, including overflow. When a child has lifelong severe constipation without encopresis, HSCR should be strongly considered.
Nutritional deficiencies — from chronic malabsorption and reduced intake; iron deficiency, protein-calorie malnutrition.
Recurrent abdominal pain — from accumulated stool and distension.

Back to Table of Contents

Hirschsprung-Associated Enterocolitis (HAEC)

Hirschsprung-associated enterocolitis (HAEC) is the most serious and life-threatening complication of Hirschsprung disease. It is an acute inflammatory condition of the bowel that can occur before surgical correction or after pull-through surgery, and it is a significant cause of morbidity and mortality in HSCR patients. The precise pathophysiology of HAEC is not fully understood, but it involves bacterial overgrowth in the obstructed, stagnant bowel lumen, disruption of the mucosal barrier, translocation of bacteria, and systemic sepsis.

Clinical features of HAEC:

Explosive, liquid diarrhea — the hallmark symptom; often described as "gushing" or "squirting" stools; classically elicited by digital rectal examination (the "squirt sign"). The explosive diarrhea occurs when accumulated, infected contents in the obstructed bowel are suddenly released.
Fever — often high; systemic signs of sepsis.
Abdominal distension and tenderness — abdominal distension may be massive; tenderness suggests transmural bowel inflammation or peritonitis.
Vomiting — bilious vomiting from obstruction.
Lethargy and hemodynamic instability — in severe cases; septic shock is possible.

Bacterial pathogens associated with HAEC: Clostridium difficile is an important pathogen, as is Staphylococcus aureus and gram-negative enteric organisms. Rotavirus has been implicated in some cases. The role of Clostridium difficile is particularly important because HAEC can be the presenting manifestation of C. difficile colitis in HSCR patients.

HAEC risk factors: Down syndrome co-morbidity, delayed diagnosis, long-segment disease, and young age all increase HAEC risk. HAEC can occur pre-operatively (in undiagnosed or diagnosed but not yet operated patients) and post-operatively after pull-through — meaning that successful surgery does not eliminate HAEC risk entirely.

Treatment of HAEC:

Rectal irrigations (rectal washouts) — the cornerstone of acute HAEC management; a tube is passed per rectum and the colon is irrigated with warm saline repeatedly until the washout is clear; this decompresses the obstructed, infected bowel. Irrigations also serve as maintenance management in the pre-operative period.
Intravenous antibiotics — metronidazole (covers anaerobes including C. difficile) plus intravenous ampicillin or a third-generation cephalosporin for gram-negative coverage. Oral vancomycin is added if C. difficile is confirmed.
Intravenous fluid resuscitation — aggressive hydration for dehydration and hemodynamic support.
Nasogastric decompression — to decompress the stomach and reduce vomiting.
Urgent surgical consultation — for diverting ostomy in cases that do not respond to conservative management, or in patients who are too sick for immediate pull-through.

HAEC that does not respond rapidly to rectal irrigations and antibiotics can progress rapidly to bowel perforation, peritonitis, and septic shock. It should be treated with urgency equivalent to other causes of acute abdomen in neonates.

Back to Table of Contents

Diagnosis — Suction Rectal Biopsy and Barium Enema

Hirschsprung disease is diagnosed by a combination of clinical suspicion, imaging, physiological testing, and — definitively — histopathology. The diagnosis must be confirmed histologically before surgical correction.

1. Suction rectal biopsy — gold standard for diagnosis:

The definitive diagnostic test is demonstration of the absence of ganglion cells on histological examination of rectal biopsy tissue. Suction rectal biopsy is preferred in infants and young children because it can be performed at the bedside without general anesthesia, using a suction biopsy device that captures a small cylinder of mucosa and submucosa from the posterior rectal wall. Key technical requirements:

Biopsy must be taken at least 2 cm above the dentate line (the normal transition zone at the anorectal junction; there is a physiological hypoganglionosis in the most distal 1–2 cm of the rectum in all normal infants, which would give a false positive if sampled too low).
The specimen must contain adequate submucosa to allow sampling of the Meissner's (submucosal) plexus. Superficial biopsies that contain only mucosa are inadequate for diagnosis.
Histological analysis looks for: absence of ganglion cells (ganglion cells are large, round neurons with prominent nucleoli normally seen in both plexuses) + increased acetylcholinesterase (AChE) staining of nerve fibers in the mucosa and muscularis mucosae (histochemical staining; increased AChE-positive fibers in the lamina propria and muscularis mucosae indicate aganglionosis). Some centers also use calretinin immunostaining — ganglion cells are calretinin-positive, and absence of calretinin staining in nerve fibers is a marker of aganglionosis that is rapidly readable on fresh frozen sections.
If suction biopsy is non-diagnostic (inadequate specimen, technical difficulty), a full-thickness surgical biopsy under general anesthesia can be performed.

2. Contrast enema (barium enema):

Not definitive, but provides valuable anatomical information. The classic finding is the transition zone: a cone-shaped or funnel-shaped narrowing where the aganglionic distal segment meets the dilated ganglionated proximal bowel. The transition zone is typically at the rectosigmoid junction in short-segment disease.
The reversed rectosigmoid ratio is a useful sign: normally the rectum is wider than the sigmoid; in HSCR (short-segment), the sigmoid is wider than the rectum because the sigmoid is the dilated ganglionated segment and the rectum is the narrow aganglionic segment.
Delayed 24-hour film: contrast retention in the colon at 24 hours after enema is an important sign — normal bowel evacuates contrast; retained contrast in HSCR reflects the failure of aganglionic bowel to propel contents.
In total colonic aganglionosis, the barium enema shows a microcolon or question-mark colon without a clear transition zone — an atypical pattern that should prompt rectal biopsy even if contrast enema appears near-normal.
Caution: Contrast enema can precipitate or worsen HAEC if the bowel is already inflamed; it should not be performed in a patient with suspected active enterocolitis.

3. Anorectal manometry:

Measures the rectoanal inhibitory reflex (RAIR) — the normal reflex relaxation of the internal anal sphincter in response to rectal balloon distension.
In HSCR, the RAIR is absent because ganglion cells required to mediate this reflex are missing from the submucosal plexus of the aganglionic rectum.
A present RAIR virtually excludes HSCR (high negative predictive value). An absent RAIR supports HSCR but requires biopsy confirmation.
Most useful in older children (requires cooperation or sedation); less reliable in neonates under 1 month of age because the reflex may be immature.

4. Genetic testing:

Multigene panel testing (RET, EDNRB, EDN3, SOX10, GDNF, and others) is increasingly recommended for familial HSCR, long-segment disease, or suspected syndromic cases. Chromosomal microarray analysis should be performed when Down syndrome or another chromosomal syndrome is suspected.

Back to Table of Contents

Differential Diagnosis

The differential diagnosis of Hirschsprung disease varies by age at presentation:

In the neonate with failure to pass meconium and abdominal distension:

Meconium ileus — the neonatal presentation of cystic fibrosis; inspissated meconium obstructs the terminal ileum; 80–90% of meconium ileus cases have cystic fibrosis. Contrast enema shows a small colon with filling defects from meconium pellets in the terminal ileum. Sweat chloride test and CF genetic testing distinguish this from HSCR.
Meconium plug syndrome (functional immaturity of the colon) — also called small left colon syndrome; transient functional obstruction from thick meconium in the descending colon; often responds to contrast enema (which is both diagnostic and therapeutic); associated with maternal diabetes and magnesium sulfate therapy; no aganglionosis on biopsy. However, HSCR can present identically — biopsy is needed in any neonate not rapidly clearing meconium after therapeutic enema.
Intestinal atresia — intrinsic bowel obstruction from a developmental gap or web in the bowel lumen; air-fluid levels on plain radiograph with a "triple bubble" or "double bubble" sign; contrast enema or upper GI study identifies the level.
Anorectal malformations (imperforate anus) — readily diagnosed on physical examination.
Hypothyroidism — congenital hypothyroidism can cause constipation, hypotonia, and delayed meconium passage; neonatal screening tests detect this, but results may not be available in the first 48 hours.

In older children with chronic constipation:

Functional constipation (idiopathic constipation) — by far the most common cause of childhood constipation; the critical clinical distinction is that functional constipation typically starts after an identifiable trigger (toilet training, dietary change, painful defecation, stressful life event) and is accompanied by encopresis (overflow soiling), whereas HSCR presents from birth without encopresis.
Hypoganglionosis and intestinal neuronal dysplasia (IND) — rare variants of enteric neuropathy with reduced or abnormal ganglion cells; some are associated with HSCR or occur as isolated conditions; pathological diagnosis required.
Hypothyroidism — acquired hypothyroidism is a treatable cause of constipation in older children; thyroid function tests should be checked.

Back to Table of Contents

Treatment — Pull-Through Surgery

Surgery is the definitive and only curative treatment for Hirschsprung disease. The goal of surgery is to remove the aganglionic segment entirely and bring normally ganglionated bowel down to the anus, restoring the ability to defecate. This is called the pull-through procedure. Multiple surgical techniques for achieving this have been developed since Swenson's original description in 1948; modern approaches achieve excellent results in most centers.

Timing of surgery:

For term neonates who are otherwise stable, the contemporary approach is a primary single-stage pull-through — definitive repair in the newborn period without a preliminary diverting colostomy. Studies consistently show equivalent or superior outcomes compared to staged repair with less morbidity, shorter hospital stay, and no colostomy-related complications.
A diverting colostomy is still performed in patients who are acutely ill with HAEC, in premature infants, in patients with very long-segment disease, or in centers where primary neonatal pull-through is not available. The colostomy allows the dilated proximal bowel to decompress and recover, with definitive pull-through performed at a later date (typically 3–12 months of age).

The three classic pull-through techniques (all remain in use; technically different but oncologically equivalent results):

Swenson procedure (1948) — the original operation; the aganglionic rectum is dissected and excised down to the anus, and normal ganglionated bowel is brought through the excised rectal cuff and anastomosed at the dentate line. Historic significance and still performed, but technically demanding close to the dentate line.
Soave endorectal pull-through (1964) — the mucosa and submucosa are stripped from the aganglionic rectal muscular cuff (leaving the muscular sleeve in place), and ganglionated bowel is pulled through the cuff to be anastomosed at the anus. Reduces risk of pelvic autonomic nerve damage.
Duhamel retrorectal pull-through (1956) — the aganglionic rectum is left in place anteriorly, and ganglionated bowel is brought down posterior to the rectum and anastomosed to the posterior rectal wall, creating a new neorectum with a ganglionated posterior wall and an aganglionic anterior wall. Technically easier; the aganglionic anterior wall gradually becomes inactive while the ganglionated posterior wall dominates function.

Contemporary approach — transanal pull-through: In the past two decades, the transanal endorectal pull-through (TEPT) — performing the entire dissection and anastomosis via a perineal/transanal approach without abdominal incisions — has become the preferred technique in many pediatric surgical centers. Advantages include no abdominal incisions, minimal blood loss, rapid recovery, and cosmetic benefit. For long-segment or total colonic disease, laparoscopic assistance is typically added to mobilize the proximal colon.

Pre-operative management: Daily or twice-daily rectal irrigations are performed from diagnosis until surgery to decompress the bowel, reduce bacterial overgrowth, and prevent HAEC.

Back to Table of Contents

Long-Term Outcomes and Complications

The majority of children with Hirschsprung disease who undergo successful pull-through surgery go on to have good or excellent quality of life, but a significant proportion experience ongoing bowel dysfunction. Long-term follow-up into adulthood is important.

Post-operative constipation (30–50%): This is the most common long-term complication. After pull-through, the newly anastomosed ganglionated bowel must adapt to its new pelvic position. Mechanical causes of post-operative constipation include:

Transition zone pull-through — the anastomosis was inadvertently placed at or near the transition zone rather than well within ganglionated bowel; this is a preventable cause of recurrence and is diagnosed by rectal biopsy of the anastomotic area.
Internal anal sphincter achalasia — the internal sphincter fails to relax appropriately after pull-through; treated with posterior myectomy or botulinum toxin injection into the sphincter.
Stricture at the anastomosis — treated with calibration or dilation.
Ongoing post-operative constipation is managed with bowel management programs, laxatives, rectal irrigation, and — for anatomical causes — reoperation.

Fecal incontinence (10–20%): Soiling or incontinence after pull-through, ranging from minor soiling to significant incontinence; more common with very low anastomoses or with damage to the external anal sphincter complex during surgery. Bowel management programs (timed enemas, dietary manipulation) significantly improve continence in most patients.

Post-operative HAEC (up to 30%): Enterocolitis can recur after pull-through, particularly in the first two years. Recurrent HAEC episodes should prompt evaluation for mechanical obstruction (stricture, transition zone pull-through) as treatable causes. Preventive rectal irrigations are used in high-risk patients.

Quality of life: The majority of adult patients with HSCR managed in childhood report good quality of life, though a subset report significant ongoing bowel dysfunction, social restrictions related to urgency or incontinence, and psychological impact. Adults who were not diagnosed in childhood and lived for years with unrecognized HSCR may have particularly complex bowel function post-operatively.

Long-term follow-up recommendations: Annual or biannual follow-up with a pediatric gastroenterologist or colorectal surgeon through childhood and adolescence; transition to adult care at appropriate age; psychological support as needed; evaluation for associated conditions (thyroid function in Down syndrome patients, MEN2A screening for RET codon-specific mutations).

Back to Table of Contents

Research Papers

Swenson O, Bill AH Jr. Resection of rectum and rectosigmoid with preservation of the sphincter for benign spastic lesions producing megacolon. Surgery. 1948;24(2):212–220. PMID: 18874765. The landmark original description of the pull-through procedure for Hirschsprung disease.
Skaba R. Historic milestones of Hirschsprung's disease (commemorating the 90th anniversary of Professor Harald Hirschsprung). J Pediatr Surg. 2007;42(1):249–251. DOI: 10.1016/j.jpedsurg.2006.09.055. PMID: 17208573.
Amiel J, Sproat-Emison E, Garcia-Barcelo M, et al. Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet. 2008;45(1):1–14. DOI: 10.1136/jmg.2007.053959. PMID: 17965226. Comprehensive genetics review including RET and associated syndromes.
Langer JC. Hirschsprung disease. Curr Opin Pediatr. 2013;25(3):368–374. DOI: 10.1097/MOP.0b013e328360c2a2. PMID: 23615177. Modern review of diagnosis and surgical management.
Gosain A, Frykman PK, Bhisitkul D, et al. Guidelines for the diagnosis and management of Hirschsprung-associated enterocolitis. Pediatr Surg Int. 2017;33(5):517–521. DOI: 10.1007/s00383-017-4065-8. PMID: 28243819. Authoritative management guidelines for HAEC.
Burkardt DD, Graham JM Jr, Short SS, Frykman PK. Advances in Hirschsprung disease genetics and treatment strategies: an update for the primary care pediatrician. Clin Pediatr (Phila). 2014;53(1):71–81. DOI: 10.1177/0009922813498130. PMID: 23940256.
Menezes M, Corbally M, Puri P. Long-term results of bowel function after treatment for Hirschsprung's disease: a 29-year review. Pediatr Surg Int. 2006;22(12):987–990. DOI: 10.1007/s00383-006-1763-8. PMID: 17024527. Long-term outcomes data over nearly three decades.
Dasgupta R, Langer JC. Hirschsprung disease. Curr Probl Surg. 2004;41(12):942–988. DOI: 10.1067/j.cpsurg.2004.08.001. PMID: 15635624. Detailed surgical review.
Heuckeroth RO. Hirschsprung disease — integrating basic science and clinical medicine to improve outcomes. Nat Rev Gastroenterol Hepatol. 2018;15(3):152–167. DOI: 10.1038/nrgastro.2017.149. PMID: 29300049. Authoritative translational review bridging pathophysiology and clinical care.
De la Torre L, Langer JC. Transanal endorectal pull-through for Hirschsprung disease: technique, controversies, pearls, pitfalls, and an organized approach to the management of postoperative obstructive symptoms. Semin Pediatr Surg. 2010;19(2):96–106. DOI: 10.1053/j.sempedsurg.2009.11.015. PMID: 20307847. Technical guide to transanal pull-through.
Tomuschat C, Puri P. RET gene is a major risk factor for Hirschsprung's disease: a meta-analysis. Pediatr Surg Int. 2015;31(8):701–710. DOI: 10.1007/s00383-015-3731-y. PMID: 26105713. Meta-analysis quantifying RET mutation prevalence across populations.
Ieiri S, Suita S, Nakatsuji T, Nakai H, Yoshioka T. Total colonic aganglionosis with or without small bowel involvement: a 30-year retrospective nationwide survey in Japan. J Pediatr Surg. 2008;43(12):2226–2230. DOI: 10.1016/j.jpedsurg.2008.08.065. PMID: 19040946. Largest study of total colonic aganglionosis outcomes.

Back to Table of Contents

Connections

Back to Table of Contents

Featured Videos

Back to Table of Contents